98 related articles for article (PubMed ID: 26665428)
1. [Efficacy of polyprenyl phosphates in the experimental genital herpes model].
Narovlyansky AN; Ivanova AM; Shevlyagina NV; Didenko LV; Borovaya TG; Izmest'eva AV; Sanin AV; Pronin AV; Ershov FI
Vopr Virusol; 2015; 60(4):9-13. PubMed ID: 26665428
[TBL] [Abstract][Full Text] [Related]
2. Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpes.
Bernstein DI; Cardin RD; Bravo FJ; Earwood J; Clark JR; Li Y; Mishra P; Li C; Nayak BP; Miller AT; Wu TY; Cooke MP; Valiante NM
Antivir Chem Chemother; 2014 Apr; 23(5):189-96. PubMed ID: 23232327
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a novel, anti-herpes simplex virus compound, acyclovir elaidate (P-4010), in the female guinea pig model of genital herpes.
Jennings R; Smith TL; Myhren F; Phillips J; Sandvold ML
Antimicrob Agents Chemother; 1999 Jan; 43(1):53-61. PubMed ID: 9869565
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic effect of gefin, a new antiviral drug, in experimental genital herpes ].
Alimbarova LM; Barinskiĭ IF; Kuz'min KK
Vopr Virusol; 2002; 47(1):34-7. PubMed ID: 11852781
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of N-methanocarbathymidine against genital herpes simplex virus type 2 shedding and infection in guinea pigs.
Bernstein DI; Bravo FJ; Pullum DA; Shen H; Wang M; Rahman A; Glazer RI; Cardin RD
Antivir Chem Chemother; 2015 Feb; 24(1):19-27. PubMed ID: 26149263
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of topical acyclovir monophosphate, acyclovir, or penciclovir in orofacial HSV-1 infections of mice and genital HSV-2 infections of guinea pigs.
Kern ER; Palmer J; Szczech G; Painter G; Hostetler KY
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):501-13. PubMed ID: 10772730
[TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of antiviral efficacy against genital herpes using mouse and guinea pig models.
Valencia F; Veselenak RL; Bourne N
Methods Mol Biol; 2013; 1030():315-26. PubMed ID: 23821278
[TBL] [Abstract][Full Text] [Related]
8. Superior efficacy of helicase-primase inhibitor BAY 57-1293 for herpes infection and latency in the guinea pig model of human genital herpes disease.
Baumeister J; Fischer R; Eckenberg P; Henninger K; Ruebsamen-Waigmann H; Kleymann G
Antivir Chem Chemother; 2007; 18(1):35-48. PubMed ID: 17354650
[TBL] [Abstract][Full Text] [Related]
9. [TREATMENT OF PATIENTS WITH CHRONIC RECURRENT HERPES VIRUS INFECTION OF GENITAL LOCALIZATION: A CLINICAL STUDY OF FORTEPREN PREPARATION].
Narovlyansky AN; Sedov AM; Pronin AV; Shulzhenko AE; Sanin AV; Zuikova IN; Schubelko RV; Savchenko AY; Parfenova TM; Izmestieva AV; Izmestieva AV; Grigorieva EA; Suprun OV; Zubashev IK; Kozlov VS
Zh Mikrobiol Epidemiol Immunobiol; 2015; (4):112-8. PubMed ID: 26470430
[TBL] [Abstract][Full Text] [Related]
10. Suppression of recurrent genital herpes simplex virus type 2 infection by Rhus javanica in guinea pigs.
Nakano M; Kurokawa M; Hozumi T; Saito A; Ida M; Morohashi M; Namba T; Kawana T; Shiraki K
Antiviral Res; 1998 Jul; 39(1):25-33. PubMed ID: 9754947
[TBL] [Abstract][Full Text] [Related]
11. An immunomodulating dipeptide, SCV-07, is a potential therapeutic for recurrent genital herpes simplex virus type 2 (HSV-2).
Rose WA; Tuthill C; Pyles RB
Int J Antimicrob Agents; 2008 Sep; 32(3):262-6. PubMed ID: 18619817
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of acyclovir-resistant herpes simplex virus type 2 proctitis with leflunomide in an HIV-infected man.
Henao-Martínez AF; Weinberg A; Waldman WJ; Levi ME
J Clin Virol; 2012 Jul; 54(3):276-8. PubMed ID: 22465339
[TBL] [Abstract][Full Text] [Related]
13. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
[TBL] [Abstract][Full Text] [Related]
14. Topical honey application vs. acyclovir for the treatment of recurrent herpes simplex lesions.
Al-Waili NS
Med Sci Monit; 2004 Aug; 10(8):MT94-8. PubMed ID: 15278008
[TBL] [Abstract][Full Text] [Related]
15. Effect of antibody alone and combined with acyclovir on neonatal herpes simplex virus infection in guinea pigs.
Bravo FJ; Bourne N; Harrison CJ; Mani C; Stanberry LR; Myers MG; Bernstein DI
J Infect Dis; 1996 Jan; 173(1):1-6. PubMed ID: 8537645
[TBL] [Abstract][Full Text] [Related]
16. [Isolation of acyclovir-resistant strains of herpes simplex virus from clinical material].
L'vov ND; Andronova VL; Leont'eva NA; Galegov GA
Vopr Virusol; 1999; 44(6):247-9. PubMed ID: 10665057
[TBL] [Abstract][Full Text] [Related]
17. Recurrent genital herpes in the guinea pig augmented by ultraviolet irradiation: effects of treatment with acyclovir.
Stanberry LR; Harrison CJ; Bravo FJ; Childs F; Reece AL; Bernstein DI
Antiviral Res; 1990 May; 13(5):227-35. PubMed ID: 2396831
[TBL] [Abstract][Full Text] [Related]
18. Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir.
Bernstein DI; Stanberry LR; Harrison CJ; Kappes JC; Myers MG
J Gen Virol; 1986 Aug; 67 ( Pt 8)():1601-12. PubMed ID: 3016155
[TBL] [Abstract][Full Text] [Related]
19. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
20. Effect of acyclovir on genital herpes in guinea pigs.
Pronovost AD; Lucia HL; Dann PR; Hsiung GD
J Infect Dis; 1982 Jun; 145(6):904-8. PubMed ID: 6282986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
